PREBIOTIC AND PROBIOTIC FOODS IN HUMAN HEALTH MAINTENANCE: WHAT IS THE COMPREHENSIVENESS?
DOI:
https://doi.org/10.13037/ras.vol13n44.2584Keywords:
Prebiotics, probiotics, dietary fiber, disease preventionAbstract
Introduction: Prebiotics and probiotics have great utility in the field of nutrition and dietetics becauseof its comprehensive properties that support a better quality of life. However, their features are not fullyelucidated, motivating research on the subject. Objectives: Show how the use of prebiotic and probioticfoods can improve various human physiological functions. Materials and Methods: This is a review of literature,whose documentary inclusion conditions consisted of books, journals, monographs, dissertationsand theses in Portuguese, English and Spanish, published between 2000 and 2013, using the followingkeywords: “functional foods”, “prebiotics”, “probiotics”, “fibers” and “intestinal bacteria”. Results: Werefound in the literature clear scientific evidence of the benefits of the using probiotics for the maintenanceof intestinal balance, as well as its use prophylactic and/or therapeutic treatment in several diseases, suchas constipation, obesity, diabetes mellitus, dyslipidemia, ulcerative colitis, short bowel syndrome, cancer,besides the improvement in the absorption of minerals such as calcium. About the use of probiotics,the evidence also suggested benefits in maintaining balance intestinal and anti-inflammatory activity, aswell as its use prophylactic and/or therapeutic treatment in several diseases, dyslipidemia, oral diseases, diarrhea, eradication of Helicobacter pylori, irritable bowel syndrome, necrotizing enterocolitis, pouchitis, cirrhosis, hepaticencephalopathy, chronic fatigue syndrome and cancer. Conclusions: The introduction of these foods in adequate amountsshould be part of the daily lives of people who value the quality of life.Downloads
References
1. Moura MRL. Alimentos Funcionais: seus benefícios e a legislação. [Internet]. Disponível em: http://acd.ufrj.br/consumo/leituras/ld.htm#leiturasKwak N, Jukes DJ. Functional foods. Part 1: the development of a regulatory
concept. Food Control. 2001;12:99-107.
2. Araújo EA. Desenvolvimento e caracterização de queijo tipo cottage adicionado de Lactobacillus Delbrueckii UFV H2b20 e de inulina [dissertação]. Viçosa (MG): Universidade Federal de Viçosa; 2007.Badaró ACL, Guttierres APM, Rezende ACV, Stringheta PC. Alimentos
probióticos: aplicações como promotores da saúde humana – parte 1. Nutrir Gerais. 2008; 2(3):1-29.
3. Brasil. Agência Nacional de Vigilância Sanitária. Diretrizes básicas para análise e comprovação de propriedades funcionais e ou de saúde alegadas em rotulagem de alimentos. Brasília;1999.
4. Sanders ME. Probiotics: considerations for human health. Nutr ver. 2003;61(3):91-9.
5. Anjo DLC. Alimentos funcionais em angiologia e cirurgia vascular. J Vasc Br. 2004;3(2):145-154.
6. Peixoto LL, Silva RPPE. Os efeitos dos probióticos e prebióticos na promoção de um organismo saudável [monografia]. Teófilo Otoni (MG): Faculdade de Educação e Estudos Sociais de Teófilo Otoni; 2008.Fuller R. Probiotics in man and animals. J Appl Bacteriol. 1989;66:365-378.
7. Holzapfel WH. Taxonomy and important features of probiotic microorganisms in food and nutrition. Am J Clin. 2001;73(2):365-373.
8. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota. Introducing the concept of prebiotics. J Nutr. 1995;125(6):1401-1412.
9. Saad SMI. Probióticos e prebióticos: o estado da arte. Rev Bras Cienc Farm. 2006a;42:1-16.
10. Holzapfel WH, Schillinger U. Introduction to pre and probiotics. Food Res Int. 2002;35 (2/3):109-116.
11. Ziemer CJ, Gibson GR. An overview of probiotics, prebiotics and synbiotics in the functional food concept: perspectives and future strategies. Int Dairy J. 1998;8:473-9.
12. Matsubara S. Alimentos funcionais: uma tendência que abre perspectivas aos laticínios. Rev Laticínios. 2001;34:10-8.
13. Salgado J. Iogurtes e leites fermentados: uma alternativa no tratamento das desordens intestinais. [Internet]. 2008. Disponível em: http://www1.uol.com.br/vyaestelar/vida_saudavel_iogurte.htmDamião AOMC. Prebióticos, probióticos e simbióticos: aplicações clínicas. CERES. 2006;1:18-24.
14. Bringel A. Bactérias a serviço da saúde. Super Saudável. 2007;7(36):14-15.
15. Millani E, Konstantyner T, Taddei JAA. C. Efeitos da utilização de prebióticos (oligossacarídeos) na saúde da criança. Rev Paul Pediatr. 2009;27(4):436-446.
16. Hond ED, Geypens B, Ghoos Y. Effect of high performance chicory inulin on constipation. Nutr Res. 2000;20:731–736.
17. Zafar T.A, Weaver CM, Zhao Y, Martin BR, Wastney ME. Non-digestible oligosaccharides increase calcium absorption and suppress bone resorption in ovariectomized rats. J Nutr. 2004;134:399–402.
18. Cani PD, Delzenne NM. The gut microbiome as therapeutic target. Pharmacol & Ther. 2011;130:202-212.
19. Sanz Y, Santacruz A, Gauffin P. Probiotics in the defence and metabolic balance of theorganism: gut microbiota in obesity and metabolic disorders. P Nutr Soc. 2010;69:434-441.
20. Brady PL, Gallaher D, Busta F. The role of probiotic culture in the prevention of colon cancer. J Nutr 2000;130:410-5.
21. Fortes RC. Os frutooligossacarídeos, a inulina e suas implicações na indústria de alimentos. Nutr Bras. 2005;4:52-61.
22. Fortes RC. Alimentos prebióticos: efeitos bifidogênicos dos frutooligossacarídeos e da inulina no organismo humano. SBRAFH. 2006;2(9):16-23.
23. Silva ASS, Hass P, Sartori NT, Anton AA, Francisco A. Frutooligossacarídeos: fibras alimentares ativas. B do Ceppa. 2007;25(2):295-304.
24. McFarlane S. Microbial biofilm communities in the gastrointestinal tract. J Clin Gastroenterol. 2008;42:142-3.
25. D’Elboux Y. Estudo demonstra ação de simbióticos na SIC. Super Saudável. 2005;25:16-9.
26. Búrigo T, Fagundes RLM, Trindade EBSM, Vasconcelos HCFF. Efeito bifidogênico do frutooligossacarídeo na microbiota intestinal de pacientes com neoplasia hematológica. Rev Nutr. 2007;20(5):491-7.
27. Brouns F, Vermeer C. Functional food ingredients for reducing the risks of osteoporosis. Trends Food Sci Technol. 2000;11:22-33.
28. Griffin IJ, Davila PM, Abrams AS. Non-digestible oligosaccharides and calcium absorption in girls with adequate calcium intakes. Br J Nutr. 2002;87(2):187-191.
29. Malaguarnera M, Greco F, Barone G, Gargante MP, Toscano MA. Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Dig Dis Sci. 2007;52:3259-3265.
30. Diniz RO, Perazzo FF, Carvalho JCT, Schneenedorf JM. Atividade antiinflamatória de quefir, um probiótico da medicina popular. Rev Bras Farmacogn. 2003;13:19-21.
31. Liong MT, Shah NP. Acid and bile tolerance and cholesterol removal ability of Lactobacilli strains. J Dairy Sci. 2005;88:55-66.
32. Kang MS, Kim BG, Chung J, Lee HC, Oh JS. Inhibitory effect of Weissella cibaria isolates on the production of volatile sulphur compounds. J Clin Periodontol. 2006;33:226-232.
33. Marteau PR, Seksik P. Place des probiotiques dans la prevention et le traitement des diarrhees post-antibiotiques. Rev Fr Lab. 2004;368:73-76.
34. Surawicz CM, McFarland LV, Greenberg RN, Rubin M, Fekety R, Mulligan ME, Garcia RJ, Brandmarker S, Bowen 0K, Borjal D, Elmer GW. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis. 2010;31:1012-1017.
35. Zhao HY, Wang HJ, Lu Z, Xu S. Z. Intestinal microflora in patients with liver cirrhosis. Chin J Dig Dis. 2004;5:64-67.
36. Lirussi F, Mastropasqua E, Orando S, Orlando R. Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis.
Cochrane Database Syst Rev. 2007;1(5165):1-14.
37. Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan S.M. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology. 2004;39:1441-1449.
38. Obregón MCL, Cruchet SM, Diaz EB, Salazar GR, Gotteland MR. El consumo regular de Lactobacillus johnsonii La1 interfiere con la colonización gástrica por Helicobacter pylori. Rev Chil Nutr. 2003;30(3):243-249.
39. Quigley EMM, Flourie B. Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date. Neurogastroenterol Motil. 2007;19:166-172.
40. Fedorak RN; Madsen KL. Probiotics and prebiotics in gastrointestinal disorders. Current Opinion Gastroenterol. 2004;20:146-155.
41. Gionchetti P, Rizzello F, Helwig U. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterol. 2003;124(5)1202-9.
42. Sullivan A, Nord CE, Evengard B. Effect of supplement with lactic-acid producing bacteria on fatigue and physical activity in patients with chronic fatigue syndrome. Nutr J. 2009;8:4-8.
43. Lara-Villoslada F, Sierra S, Boza J, Xaus J, Olivares YM. Efectos beneficiosos en niños sanos del consumo de un producto lácteo que contiene dos cepas probióticas. Lactobacillus coryniformis CECT5711 y Lactobacillus gasseri CECT5714. Nutr Hosp. 2007;22(4):496-502.
44. Passos LML, Park YK. Frutooligossacarídeos: implicações na saúde humana e utilização em alimentos. Ciência Rural. 2003;33(2):385-390.
45. Chinda D, Nakaji S. The fermentation of different dietery fibers is associated with fecal clostridia levels in men. J Nutr. 2004;134:1881-1886.
46. Kaur N, Gupta AK. Applications of inulin and oligofructose in health and nutrition. Biosci J. 2002;27:703-714.
47. Saad SMI. Alimentos Funcionais: probióticos e prebióticos. In: Tirapegui J. Nutrição: fundamentos e aspectos atuais. 2ª ed. São Paulo: Atheneu; 2006b. Lobo AR. Efeito dos frutanos (frutooligossacarídeos) na biodisponibilidade de cálcio e magnésio em ratos. dissertação] São Paulo (SP): Faculdade de Ciências Farmacêuticas;2004.Begley M, Hill C, Gahan CGM. Bile salt hydrolase activity in probiotics. Appl Environ Microbiol. 2006;72(3):1729-1738.
48. Burton JP, Chilcott CN, Moore CJ, Tagg JR. Effect of probiotic Streptococcus salivarius K1 2 on oral malodour parameters. Oral Dis. 2005;11:29-31.
49. Petti S, Tarsitani G, D’Arca AS. A randomized clinical trialof the effect of yoghurt on the human salivary microflora.
Arch Oral Biol. 2001;46(8):705-712.
50. Tong JL, Ran ZH, Shen J, Zhang CX, Xiao S. D. Metaanalysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther.2007;25:155-168.
51. Bringel A. Probióticos ajudam a melhorar fadiga crônica. Super Saudável. 2010;1:12-5.
52. Heburtene X. Gut changes attributed to ageing: effects on intestinal microflora. Curr Opin Clin Nutr Metab Care. 2003;6:49-54.
53. Saarela M, Mogensen G, Fonde R, Maltto J, MattilaSandholm T. Probiotic bacteria: safety, functional and technological properties. J Biotechnol. 2000;84:197-215.
54. Roberfroid MB. Simpósio Internacional Orafti sobre os benefícios nutricionais da inulina e oligofructose. Programa e resumos. 2004; p.14-7.
Downloads
Published
Issue
Section
License
Copyright (c) 2015 Bruna Yhang da Costa Silva, Tiago Freire Martins
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Policy Proposal for Journals offering Free Delayed Access
Authors who publish in this magazine agree to the following terms:
- Authors maintain the copyright and grant the journal the right to the first publication, with the work simultaneously licensed under a Creative Commons Attribution License after publication, allowing the sharing of the work with recognition of the authorship of the work and initial publication in this journal.
- Authors are authorized to assume additional contracts separately, for non-exclusive distribution of the version of the work published in this magazine (eg, publishing in institutional repository or as a book chapter), with the acknowledgment of the authorship and initial publication in this journal.
- Authors are allowed and encouraged to publish and distribute their work online (eg in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes, as well as increase impact and citation of the published work (See The Effect of Open Access).
